SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression

Table 2

Univariate and multivariable analyses for SHMT2 in OS in CRC patients.

	OS
	HR (95% CI)		n (events)
Univariate
SHMT2 negative	1		37 (2)
SHMT2 positive	5.217 (1.26–21.61)	0.023	164 (39)
Multivariable
SHMT2 positive	4.440 (1.07–18.41)	0.040
T stage
T3+4 versus T1+2	1.731 (0.98–3.07)	0.061
M stage
M1 versus M0	1.082 (0.47–2.49)	0.853
N stage
N1+2 versus N0	1.564 (1.01–2.43)	0.047

Note. Multivariable analysis adjusted for age, gender, T stages, N stages, and M stages.